Cipla
Ranjan Lokegaonkar has extensive experience in the field of analytics, currently serving as the Head of Digital Advance Analytics at Cipla since April 2022. Prior to this role, Ranjan held the position of Team Lead - Advanced Analytics at Accenture from May 2019 to April 2022 and worked as a Data Scientist at ZS from June 2017 to May 2019. Ranjan began their career as a Business Analyst at Reliance Retail, focusing on live analytical solutions for a retail client, and served as a Project Trainee at Nelco Ltd., where responsibilities included developing electronics kits for production efficiency. Ranjan holds a Bachelor of Engineering degree in Electrical, Electronics and Communications Engineering from the University of Mumbai and a Diploma in Industrial Electronics Technology from Agnel Charitable Trusts Fr Conceicao Rodrigues Institute of Technology.
This person is not in the org chart
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.